Low dose radiation and intercellular induction of apoptosis: potential implications for the control of oncogenesis

Abstract

Purpose: This review is focused on the potential impact of low dose radiation effects on intercellular induction of apoptosis and the underlying reactive-oxygen species (ROS)-mediated signaling pathways.

Results: Transformed cells are subject to ROS-mediated apoptosis induction by non-transformed cells (‘intercellular induction of apoptosis’) and by ROS-mediated autocrine self-destruction. Sensitivity to intercellular induction of apoptosis and autocrine self-destruction are strictly correlated to the expression of the transformed state. Extracellular superoxide anions generated by transformed target cells drive the selectivity and sensitivity of this signaling system which is based on four different signaling pathways. Low dose irradiation of non-transformed cells enhances intercellular induction of apoptosis in transformed cells. This process is controlled by TGF-beta and seems to depend on the induction of peroxidase release. In addition, low dose radiation enhances superoxide anion generation of transformed target cells.

Conclusions: Low dose radiation-triggered enhancement of intercellular induction of apoptosis and autocrine selfdestruction might represent a potential control system during carcinogenesis. It might be the underlying mechanism for the well-known inhibitory effect of low dose radiation on detectable transformation events. However, modifications of the complex intercellular ROS-based signaling system may also lead to configurations in which low dose radiation attenuates ROS-mediated apoptosis induction.

Keywords:

• Low dose radiation
• reactive oxygen
• apoptosis

Notes

1. Transformed cells are defined in the context of this article as having the potential for tumorigenesis without having yet been confronted to natural antitumor mechanisms of an organism and the resultant selection processes.

2. Tumor cells are defined in this article as having been isolated from an in vivo tumor.